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Abstract 
Osteoporosis in men is an under-diagnosed condition related to aging, which surfaces in the 
presence of fractures. Because it is a disease more commonly associated with women, its impact 
on men is less understood. Men make up 20% of the population diagnosed with osteoporosis. As 
the population ages, osteoporosis and associated fractures will impact public health in costs of 
treatment and recovery, and in costs related to long-term care. Standards used to diagnose 
osteoporosis and determine fracture risk in women were not established with men in the baseline 
population, so controversy exists in using the same diagnostic tools to determine fracture risk in 
men. More studies are necessary to determine if use of these measures can accurately diagnose 
osteoporosis and assess fracture risk in men. 
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Osteoporosis in Men: An Increasing Concern 
Osteoporosis is a prominent health problem in the United States with ten million women 
and men, age fifty and older, estimated to have the disease. Although eighty percent of those 
with osteoporosis are women, the prevalence in men is increasing, likely due to increased 
recognition of the problem through research in osteoporosis. Projections from the National 
Osteoporosis Foundation (NOF) for 2020 estimate that 14 million people in the United States 
will have osteoporosis, with men age fifty and older representing nearly one quarter of this 
figure. Low bone mass is the primary predictor for osteoporosis. Together, low bone mass and 
osteoporosis present a major public health threat for 44 million women and men in the U.S. age 
fifty and older (National Osteoporosis Foundation, 2002). 
Osteoporosis and its impact from a public health perspective. Osteoporosis is a serious 
public health problem with increasing implications as the population ages (National Osteoporosis 
Foundation, 1998). It is known as the "silent disease" as bone loss occurs usually without 
symptoms, and rarely is identified prior to the incidence of fracture, primarily vertebra, hip, and 
wrist fractures. Osteoporosis accounts for over 1.5 million bone fractures per year, with 700,000 
vertebral fractures and 300,000 hip fractures. The cost for treatment, recovery and rehabilitation 
in hospitals and nursing homes for osteoporotic fractures is an estimated $17 billion per year, an 
astounding $46 million every day (National Osteoporosis Foundation website, 2002). Hip 
fractures make up $10 billion of the total costs, with $2.7 billion attributable to osteoporosis in 
men (Anderson, 1998). Although vertebral fractures are more than double the number of hip 
fractures, the burden of care and a significant public health concern lies in the long-term care 
costs in the recovery, rehabilitation, and disability related to hip fractures. 
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In 2001, medical costs for a single hip fracture were over $40,000 (National Osteoporosis 
Fonndation, 2002). Aside from the immediate costs in treatment, recovery and rehabilitation, 
25% of people suffering a hip fracture will require costly long-term care. Costs continue to 
escalate as disability and other health conditions emerge. Quality oflife following hip fracture is 
often altered. Half of those who have a hip fracture will not be able to walk without assistance or 
an ambulation aid, and mental health problems such as anxiety and depression are common, 
often related to fear of falling or suffering additional fractures (National Osteoporosis 
Fonndation, 2002). Additionally, hip fracture is associated with the highest morbidity and 
mortality rates, with a 10 -20 %mortality rate six months after the incident. 
Men and osteoporosis. The National Institutes of Health recognizes osteoporosis as a 
major public health threat for men. Although men do not experience the rapid bone loss observed 
in women during the postmenopausal years, bone loss may occur, beginning later in life and 
progressing slowly. Osteoporosis is the most common bone disease in men, and a probable 
predictor of disability, as men may be more likely than women to become disabled following an 
osteoporotic vertebral fracture (Anderson, 1998). Research on osteoporosis in men is limited, but 
has increased in that last few years as more attention has focused on the problem. Issues that 
require further study relate to finding appropriate predictors of risk and indicators to diagnose 
osteoporosis in men and whether existing treatments, primarily tested on postmenopausal 
women, will work similarly for men. 
Is it appropriate set guidelines to test men for osteoporosis? As the general population 
ages, and fracture rates are on the rise for both men and women, the question arises related to 
who should be tested and when. Guidelines for bone mineral density (BMD) testing are 
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on studies specific to white postmenopausal women. Their recommendation includes the need 
for more research to build data for men and women of all races (National Osteoporosis 
Foundation, 1998). In theory, the greater incidence of osteoporosis as predicted for the future 
may occur as evidenced by increased an aging population, presence of risk factors, sedentary 
lifestyle and poor nutrition. The question- to minimize risk of hip fracture and associated 
secondary problems and costs, at what age are men appropriate for BMD screening to determine 
if osteoporosis is present and treatment needed. 
Etiology of Osteoporosis 
Osteoporosis, as defined by the NOF, is a skeletal disease "characterized by low bone 
mass and structural deterioration ofbone tissue leading to bone fragility and an increased 
susceptibility to fractures of the hip, spine and wrist". It is popularly associated with aging, but is 
not considered a normal part of aging (National Osteoporosis Foundation website, 2002). Peak 
bone mass is achieved by ages 18-20, and without proper nutrition and stimuli to support normal 
maintenance, bone loss begins to occur. 
Structure and formation of normal bone. Bone is connective tissue that makes up the 
skeletal system. Among its primary functions, bone tissue provides support, leverage for 
movement, and protection of various organs. It is vascular in comparison to articular cartilage, 
which is necessarily avascular as it lines the surfaces of bone that meet to form joints. Bone 
tissue provides storage for important minerals such as calcium and phosphorous, which are 
essential most notably for nervous and muscular tissue functions. Table I summarizes the major 
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Table 1 
Comparison of Components of Bone Structure 
Osteoblast Osteoclast 
derived from osteoprogenitor cell derived from fusion of mononuclear 
found on surface of mature or cells from bone marrow 
remodeling bone found close to bone surface 
responsible for deposition and active in removal and demineralization 
mineralization of bone of bone 
'-'u'"ll'''" (Compact) Bone Trabecular (Spongy) Bone 
lamellae are arranged in parallel or lamellae are branched to form a mesh or 
spiraled concentric cylinders, or lattice type formation, or trabeculae 
osteons primary bone tissue of short, flat, and 
provides protection and support, irregular bones 
strengthens long bones contains large spaces filled with red 
dense layer with few spaces that marrow 
surrounds trabecular bone osteocytes receive nourishment directly 
osteocytes receive nourishment via from blood supply in the marrow 
canaliculi network cavities 
Periosteum Endosteum 
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dense, fibrous outer covering of bone inner layer ofbone that lines the 
not covered by articular cartilage medullary cavity 
iuner osteogenic layer contains blood contains osteoprogenitor cells, 
supply, elastic fibers, osteoprogenitor osteoblasts and in lesser amounts, 
cells, osteoblasts and osteoclasts osteoclasts 
outer fibrous layer is point of 
attachment for ligaments and tendons 
essential for bone nutrition, growth and 
repmr 
Note. From Principles of anatomy and physiology (6th ed.) by G. L. Tortora, & N. P. 
Anagnostakos, 1990, p. 143-147; Gray's Anatomy (37th ed.) edited byP. L. Williams, R. 
Warwick, M. Dyson, & L. H. Baunister, 1989, p. 293-311. 
The cellular components of bone are the osteoprogenitor cells, osteocytes, osteoblasts and 
osteoclasts. Osteoprogenitor cells are stem cells that differentiate into osteoblasts, the primary 
cell responsible for the deposition ofbone (Williams, Warwick, Dyson, & Baunister, 1989). 
Osteocytes are derived from osteoblasts, and are the major cell type in bone structure. 
Osteoclasts are multinucleated, formed via fusion of mononucleated macrophages. They are 
probably derived from a cell lineage similar to stem cells that differentiate into white blood cells 
(Williams et al., 1989). 
Extracellular bone tissue is composed of organic and inorganic substances. In early 
development, bone structure is created as inorganic salts are deposited over a collagen 
foundation in a process called mineralization. Collagen contributes to bone strength and 
resistance to tensile, compressive, and shearing forces. It provides some elasticity, increasing 
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resistance to fracture. Mineral salts, which give rigidity and hardness to bone, are comprised 
primarily of calcium and phosphate. Other minerals, most in trace amounts, include copper, zinc, 
chloride, iron, potassium, aluminum, lead and silicon (Williams et al., 1989). 
Bone strength results from the specific arrangement of the cellular and extracellular 
components (Williams et al., 1989). The basic structure is in organized plates called lamella, 
arranged in continuous layers. These layers make up two functionally different structures: 
cortical bone and trabecular bone. Cortical, or compact, bone is very dense, with lamellae 
arranged in closely bound parallel or spiraled concentric cylinders. Oriented parallel to the bone 
surface, it provides the shell around the inner bone structure and gives bone its strength. In 
trabecular bone, also termed cancellous or spongy bone, the lamellae branch to create a mesh or 
lattice type structure, leaving open spaces for red marrow formation and storage. It is generally 
oriented to the surface of bone, but also in line with mechanical stresses, providing fracture 
resistance. 
Bone growth is appositional; layers ofbone are added to existing surfaces by osteoblasts. 
As the osteoblasts become enclosed within newly formed bone, they differentiate into osteocytes, 
the primary cell type of bone structure. Deposition of bone is balanced by the removal, or 
resorption, of bone by osteoclasts. Resorption is the process that releases needed minerals into 
the bloodstream for use in other physiological functions. All bones remodel at various rates of 
turnover, some with complete turnover in months, others never experiencing complete turnover 
in a lifetime. Increased stresses boost the rate of remodeling; with the balance preserved in 
deposition and resorption, healthy bone ensues. hnbalance may result in unhealthy bone 
formation. Bone deposition increases with constant mechanical tension or gravitational stress, 
leading to painful conditions such as arthritis and bone spurs. Resorption increases when such 
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stresses are removed. Extreme examples of removal are long-term bed rest or the zero gravity 
affects of being in space. 
Bone mineralization and remodeling occur in two areas, the periosteum and the 
endosteum. The periosteum is a vital bi-layered fibrous covering of bone not covered by articular 
cartilage. It provides a point of attachment for ligaments and tendons (Tortora & Anagnostakos, 
1990). Its outer layer is fibrous connective tissue that contains blood and lymph vessels, and 
nervous tissue. The vascular inner layer of the periosteum is osteogenic: it contains elastic fibers, 
osteoprogenitor cells, osteoblasts and osteoclasis. The periosteum is essential for bone growth, 
repair, and nutrition. In growth and remodeling, bone is added externally and removed internally 
(Williams eta!., 1989). The endosteum lines the medullary cavity and contains osteoprogenitor 
and osteoblast cells, along with osteoclasts. 
In men and women, the direction and rate of bone growth differ because they are 
regulated differently. Normal growth in the periosteum and endosteum are influenced by 
estrogen and testosterone. In prepuberty, testosterone stimulates periosteal bone deposition, 
increasing bone diameter in males. Estrogen limits radial and longitudinal growth, affecting 
thickness and long bone length in females. At puberty, periosteal growth progresses in males, 
thus increasing cortical thickness without changing the medullary diameter. In females, 
periosteal expansion stops as endosteal growth continues, decreasing the medullary diameter 
(Seeman, 1999). Differences in skeletal size in men and women are due to males entering 
puberty approximately 2 years after females; growth velocity in the appendicular skeleton is 
faster during prepuberty, axial growth is more rapid during puberty. Thus, men have longer and 
wider long bones with a slightly thicker cortex and are ultimately taller than women, but in 
sitting, trunk height is near equal (Seeman, 2002; Seeman, 1999). Estrogen deficiency leads to 
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periosteal growth and stimulation of length in long bones; testosterone deficiency leads to L 
decreased periosteal growth and a smaller axial and appendicular skeleton (Seeman, 1999). 
The greater strength oflong bones in men compared to women results from differences in 
size, not density. Growth builds bigger bones rather than bones that are denser. This is 
reasonable considering that denser bones would be heavier and require more metabolic support 
(Seeman, 2002). Gender differences are more likely due to differences in bone width and length. 
The larger skeleton in men equals stronger bone, which overall can tolerate a larger load, but 
load tolerance per unit area, or stress, is no different between men and women. 
Men versus women in bone loss during aging. Maintaining balance in bone 
mineralization and remodeling is the goal of homeostasis, but more commonly, bone loss occurs, 
associating it with aging. The prevalence oflow bone mass and of osteoporosis increases with ~ age (National Osteoporosis Foundation, 1998). After longitudinal growth has stopped, and peak 
bone size and peak bone mineral density (BMD) is reached, bone remodeling continues on the 
endosteal surfaces. Once growth stops, bone mass and density change little (Kanis, 2002), but 
any bone loss due to aging probably begins at this point (Seeman, 2002). Bone loss may begin 
well before menopause in women or age 50 in men, due to hormone changes as well as a less 
active lifestyle. During aging excessive resorption on the inner (medullary) and trabecular 
surfaces, reduced bone formation, or both contribute to cortical thinning and loss of trabeculae. 
Simultaneously, periosteal bone formation partly offsets this removal of bone on the inner 
surfaces. The net effect of bone formation on the outer surfaces and simultaneous resorption on 
the inner surfaces may not produce a change in BMD, yet changes in bone composition and 
strength have occurred (Seeman, 2002). 
!--
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The net loss of bone from this process is less in men than in women because during the 
growth years, periosteal apposition is greater in men. In contrast, the absolute amount of bone 
resorbed on the inner surface and formed on the outer surface is more in men than in women, as 
the larger bones in men may tolerate greater bone loss, yet produce an equivalent amount of 
fragility (Seeman, 2002; Seeman, 1999). This is partly due to better preservation of trabecular 
surfaces for remodeling in men (Seeman, 1999). Although the absolute amount of trabecular 
bone lost from young adulthood to old age is similar between the sexes, women experience 
accelerated trabecular bone loss with estrogen deficiency at menopause. It is at this time that 
bone loss is greater in women than in men. With continued aging, trabecular bone loss slows in 
women, but continues in men. Where women already have compromised bone loss and porosity 
on the trabecular surfaces, as bone resorption continues in men, bone loss results in trabecular 
thinning (Seeman, 2002). 
Diagnosis of low bone mass and osteoporosis. Diagnosis of osteoporosis is dependent on 
assessment of bone mass and quality, but there is no accepted standard for clinical measurement 
of quality (Kanis, 2002). Bone mass is measured in the hip by bone densitometry using dual X-
ray absorptiometry (DXA), currently the accepted standard in the diagnosis of osteoporosis. 
DXA measures bone mineral content, and when divided by the area (length and width) 
measured, gives a two dimensional measurement of bone mineral density, versus a three 
dimensional view that would include depth. Thus, bone size affects the apparent density as the 
relationship between area and volume is non-linear (Kanis, 2002). A limitation in this 
measurement arises when bone growth is interpreted as an increase in bone density, where the 
case is actually bigger, not denser, bone. 
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Table 2lists the thresholds, or cut-offpoints, ofBMD measurement that define four 
diagnostic categories proposed by the World Health Organization (WHO) and International 
Osteoporosis Foundation to diagnose osteoporosis (Kanis, 2002). A graphical representation of 
the reference population and diagnostic ranges for osteoporosis is shown in Figure 1. BMD 
values are expressed as aT score, in units of standard deviation (SD) from the reference mean in 
a population of healthy young women, primarily premenopausal white women. The WHO 
defines osteoporosis based on the relationship between BMD and fracture risk in postmenopausal 
women. Using current accepted BMD assessment tools, these criteria may not be accurate in the 
diagnosis of osteoporosis in all women or in men (Duthie, 2001 ), but should be considered when 
establishing the standard for diagnosis (Melton, Orwoll, & Wasnich, 2001). 
Table 2 
Diagnostic Categories for Bone Mineral Density (BMD) Measured at the Hip 
Normal greater than 1 SD below the reference mean T score 2-1 
Low Bone Mass less than 1 SD below reference mean but T score < -1 and> -2.5 
greater than 2.5 SD 
Osteoporosis equal or less than 2.5 SD below the reference T scores -2.5 
mean 
From "Diagnosis of osteoporosis and assessment of fracture risk", by J. A. Kanis, 2002, The 
Lancet, 359, p. 1930. 
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Figure 1 
Bon-e mtnera£ density (T score} 
Figure 1. Distribution of bone mineral density in healthy women aged 30-40 years. Note. From 
"Diagnosis of osteoporosis and assessment of fracture risk", by J. A. Kanis, 2002, The Lancet, 
359, p. 1930. Copyright 2002, the Lancet Publishing Group. 
Osteoporosis is characterized as either primary or secondary. Primary osteoporosis occurs 
in men and women at all ages but generally follows menopause in women and occurs gradually 
with aging in men. Secondary osteoporosis results from other conditions or diseases and the use 
of steroidal medications for the treatment of many of the associated diseases. Disorders 
associated with osteoporosis and increased fracture risk include hypogonadism, genetic 
disorders, endocrine disorders, gastrointestinal diseases, nutritional deficiencies, drug abuse, and 
many serious chronic systemic disorders, such as congestive heart failure, end-stage renal 
disease, and alcoholism. The distribution of the most common causes differs by demographic 
group, but in men, 30 to 60 percent of osteoporosis is associated with secondary causes: 
glucocorticoid use, hypogonadism, and alcoholism are the most common. In perimenopausal 
women, more than 50 percent of osteoporosis is associated with secondary causes, the most 
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common being hypoestrogenemia, glucocorticoid use, thyroid hormone excess, and 
anticonvulsant therapy. In postmenopausal women, the prevalence of secondary osteoporosis 
may be lower (National Institutes of Health, 2000). 
Hypogonadism is a risk factor associated with osteoporosis in men, but the direct 
relationship is not fully understood (Bauer, 2002). Low testosterone levels define a hypo gonadal 
state, but low testosterone levels are not causally associated with osteoporosis. Recent studies 
demonstrate that estrogen levels are much more likely to have an effect on bone mass than 
testosterone, even in men. In a prospective study linking estrogen effects to growth in the male 
skeleton, Khosla, Melton, and Riggs (2002) found evidence that estrogen is important for 
optimal bone mass acquisition in young men, and declining levels of estrogen may contribute to 
age-related bone loss in men. Low testosterone levels are not associated with these findings. 
Although this inference suggests estrogen, not testosterone, deficiency may have a causal 
relationship to osteoporosis, is does not necessarily dispute that low testosterone levels are 
associated with the condition. Sufficient studies to support this relatively new discovery need to 
be done to further understand the relationships of estrogen and testosterone in the development 
and maintenance of bone health. 
Risk factors for osteoporosis and fracture. Risk factors for osteoporosis are much the 
same as the risk for fracture. In osteoporosis, bone fragility leads to fractures that represent the 
major clinical and public health problem of the disease. Low bone mass, or osteopenia, is an 
important predictor of osteoporosis and fracture risk, but other factors may contribute, such as 
balance problems and limited mobility that increase the risk of falling, of which fracture may be 
a consequence with or without the presence of osteoporosis. Risk factors associated with low 
bone mass and osteoporosis are well documented in the literature, and supported by evidence in 
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large prospective studies (National Institutes of Health, 2000). Genetics is most important to 
determine peak bone mass in early adulthood; thus family history of osteoporosis is a risk factor 
for osteoporosis and fracture (Atkinson & Ward, 2001). Table 3 identifies predictors oflow bone 
mass, which include female gender, increased age, estrogen deficiency, white race, low weight 
and low body mass index (BMI), family history of osteoporosis, smoking, and history of prior 
fracture. Conversely, increased bone mass is associated with regular physical activity and 
increased BMI. 
Table 3 





Low body weight and low BMI 
Family history 




Note. From "NIH consensus statement: Osteoporosis prevention, diagnosis, and therapy", 
National Institutes of Health, 2000, March 29, 17(1), p. 9. 
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Several additional risk factors are associated with osteoporosis. One of the most 
important is use of prescription glucocorticoid steroids, which is strongly associated with 
secondary osteoporosis (Kanis, 2002). Long-term immobilization, low dietary calcium intake, 
and Vitamin D deficiency round out the list of strongly associated factors; weaker associations 
are linked to excessive alcohol, caffeine and protein consumption. Risk factors for men and 
women are similar, but those highly associated with men are outlined in Table 4. 
Table 4 
Risk factors for Osteoporotic fractures in men 
White or Asian Hypogonadism 
Family history of osteoporosis History of organ transplant 
Presence of certain diseases such as Cushing 
disease and gastrointestinal diseases 
Excessive alcohol consumption Increased consumption of sodium, protein, caffeine 
Inactive lifestyle sedentary 
Note. From "NIH consensus statement: Osteoporosis prevention, diagnosis, and therapy", 
National Institutes ofHealth, 2000, March 29, 17(1), p. 9-11. 
Determining the risk of osteoporosis or fracture by scoring risk factors shows low 
specificity and sensitivity to predict either BMD or fracture risk (Kanis, 2002). However, the 
presence of strong risk factors may necessitate diagnostic use of densitometry. Major clinical risk 
Osteoporosis in Men 17 
factors are estrogen status, history of fracture, maternal history of hip fracture, primary 
hypogonadism, use of glucocorticoids, and low body mass index, (Kanis, 2002; Khan, Brown, 
Kendler, Leslie, Lentle, Lewiecki, Miller, Nicholson, Olszynski, & Watts, 2002). 
Low BMD is established as an important risk factor for fracture, but this risk is also 
associated with a history of falls. The predictors of fall risk blend with many of the predictors for 
low bone mass, such as increased age, low physical activity, and low BMI. In addition, risk of 
fall is associated with poor vision, reduced mobility, slowed gait, decreased strength, impaired 
cognition, treatment with sedatives, and the presence of environmental hazards. In a cyclical 
manner, risk factors for falling are a strong predictor of fracture in the elderly (Kanis, 2002), and 
affect the fracture incidence through their effects on both bone density and the propensity to fall 
(National Institutes of Health, 2000). 
Treatment of low bone mass and osteoporosis. Proper nutrition and exercise are widely 
accepted methods to minimizing the risks of osteoporosis (Table 5). Proper nutrition includes 
adequate calcium and vitamin D intake. Several studies show that calcium and vitamin D 
supplementation reduces bone loss in older persons and can lead to statistically significant 
reductions in fracture rates (Lesser, 2000). Exercise is best if it is a weight bearing activity such 
as walking or weight training. An additional important lifestyle modification is to quit smoking. 
The NOF considers hormone replacement therapy for postmenopausal women the most 
beneficial and cost-effective treatment, but no counterpart for men exists. Two other main 
treatments are FDA approved osteoporosis medications, alendronate (marketed as FOSAMAX) 
and calcitonin. These medications are shown to be effective for treating osteoporosis and low 
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Table 5 
Public health recommendations to reduce osteoporosis 
• Ensure that adults receive the optimal daily intake of calcium- between 1000 mg and 
1500 mg. This intake is recommended for people taking specific medication for 
osteoporosis as well as for those who are not. Sources are through adequate dietary 
intake, or supplements. 
• Ensure that people at risk for vitamin D deficiency receive 400 IU of vitamin D daily. 
Sources of vitamin Dare proper diet and sunlight, or supplements if necessary. 
• Inform people that exercise, in addition to its other benefits, can help prevent 
osteoporotic fractures. 
• Strongly and consistently discourage people form smoking and recommend that those 
who already smoke should stop. 
Note. From summary," 
International, Supp/.4, p. S5. 
Even with many accepted and widely used treatment methods, controversy about 
treatment for osteoporosis lies in whether treatment is to relieve the condition or to reduce 
fracture rate. There is a distinction between diagnosis of osteoporosis and assessment of risk for 
fracture (Kanis, 2002). Changing bone density need not be the primary goal of treatment; rather, 
treatment should focus on reducing fracture rate or relieving symptoms, such as pain from the 
presence of fractures. The decision to treat should be based on its ability to minimize the risk for 
fracture, considering cost effectiveness (Kanis, 2002), versus diagnosis of osteoporosis. 
Standards regarding screening for osteoporosis are not established, although recommendations 
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have been made by the WHO and NOF. Bone densitometry, or DXA, is the standard for BMD 
diagnosis, but its use is not recommended for everyone. The NOF recommends that patients be 
screened only if it would influence the decision to start treatment. A history of previous fragility 
fractures is often considered sufficient to initiate treatment even without diagnosis by DXA and 
men and women over 80 years old generally are appropriate for treatment without diagnosis by L 
DXA, especially ifthere is a history of fragility fractures (Fogelman, 1999). 
Questions regarding osteoporosis or low bone mass treatment persist: at what age should 
treatment start, who should be treated, and for how long? Most projections for prevalence of 
L 
osteoporosis and effects of treatment are based on 10-year estimates. This is a semi-arbitrary 
selection, as long-term effects are not known for many FDA approved medications, and thus 
standards are not established for how long treatment should be continued. For example, 
FOSAMAX indications and contraindications are based on findings from 2- and 3-year clinical 
trials whose subjects are primarily postmenopausal women. Only one 2-year clinical trial 
included men, as noted in the FOSAMAX product information literature. It recognizes that data 
on men is limited pending more studies, which are ongoing (Merck & Co., 2002). Treatment 
recommendations are based on a five-year plan. Consequences of beginning treatment at a 
younger age must be considered: iflow BMD is found in a 55 year old, then five years of 
treatment is likely to be irrelevant by age 75 or 80, when the risk for fracture is greater 
(Fogelman, 1999). It is not known if treatment regimes that stretch over a significant period, such 
as 30 years, would produce more complications than long-term benefit. 
Pathogenesis of osteoporotic fractures 
A major and costly clinical consequence of osteoporosis is fracture. These are often low 
trauma fractures in older persons, and most are due to osteoporosis (Anderson, 1998). This type 
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of fracture, termed fragility fracture, is uncommon in youth, but incidence increases with age and 
is high in the elderly. Fractures associated with osteoporosis are important for measures of 
morbidity and mortality. Vertebral fractures account for the highest number of osteoporotic 
fractures, and are associated with chronic and often disabling pain. Although these fractures can 
be treated conservatively with rest, pain management, and simple bracing for a full recovery, 
they can also lead to chronic pain and disability, even death. The level of disability varies: there 
may be slight limitations in mobility, necessitating use of a cane to walk, to bedridden, requiring 
nursing home care (National Osteoporosis Foundation, 1998). Though half the numbers as 
vertebral fractures, hip fractures are associated with the most severity and highest cost in 
financial resources and in morbidity and mortality. As most hip fractures occur in people aged 80 
and older (Fogelman, 1999), a continuing rise in incidence and prevalence, along with rising 
costs for long-term care, is expected as the population ages. 
Hip fracture risk and long term effects. Hip fractures are increasing in most countries and 
the rate is increasing more rapidly in men than in women (Anderson, 1998). Just as diagnosis of 
osteoporosis increases with age, so does hip fracture risk. The lifetime risk for osteoporosis in 
white women age 50 and older is one in six, close to the risk for hip fracture (Kanis, 2002). In 
the U.S., the probability that a 50-year-old will have a hip fracture in their lifetime is as much as 
14 percent, or one in seven. White women are most at risk, but the risk in men is nearly half that 
for women. Table 6 outlines the percent of the U.S. population at risk for hip fracture. 
fi 
' l L 
~-
Table 6 
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Note. From the National Institntes of Health, March 29, 2000, NIH consensus statement: 
Osteoporosis prevention, diagnosis, and therapy 17(1), p. 6. 
The effects of hip fracture have a profound impact on quality of life; however, little 
information exists on the relationship between fractures and a person's well being (National 
Institutes of Health, 2000). Only one third of those who experience a hip fracture return to a pre-
fractnre level of function, thus, quality-of-life issues become tantamount to treatment and 
recovery. Following an osteoporotic fractnre, many areas of daily living are affected, leading to 
increased dependency on others and decreased independence in daily activities such as dressing, 
cooking, and light housekeeping. Fear, anxiety, and depression are often associated with a 
diagnosis of osteoporosis. Costs associated with hip fracture for hospital and long-term care are 
in excess of$10 billion annually, but less is known about the considerable indirect costs such as 
lost wages or productivity of either the individual or the caregiver (National Institutes of Health, 
2000). 
One third to half of the patients who survive a hip fracture are admitted to nursing homes. 
Conversely, residents of nursing homes and other long-term care facilities are at a high risk for 
hip fracture. Most of these at-risk residents have low BMD and a high prevalence of other risk 
factors for fracture (Table 7), including advanced age, poor physical function, low muscle 
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strength, decreased cognition and high rates of dementia, poor nutrition, and, often, use of 
multiple medications (National Institutes of Health, 2000). Most of these established risk factors 
for hip fracture are preventable, such as poor nutrition and weakness. Assessment of nursing 
home residents for nutritional deficiencies is recommended, and providing calcium and Vitamin 
D supplements may reduce risk of hip fracture if a deficiency is present (Seeman, 1999). 
Table 7 
Risk factors related to hip fracture 
Resident of nursing home Low bone mineral density at 
Advanced age femoral neck 
Poor mobility Muscular weakness, especially 
History of falls in the quadriceps muscle 
History of fractures Decreased cognition/ 
Poor nutrition increased dementia 
Note. From and treatment of in older men," by E. H. Duthie, June 29, 
2001; National Institutes of Health, March 29, 2000, NIH consensus statement: Osteoporosis 
prevention, diagnosis, and therapy 17(1), p.l2. 
Risk comparison in men and women. Men and women who sustain fragility fractures 
have reduced BMD, with bone loss generalized but most severe at the site of the fracture. 
Measurement of BMD in the hip has the highest predictive value for hip fracture, and studies 
show that in elderly women, the risk of fracture doubles for each SD reduction in BMD (Kanis, 
2002). More women than men experience hip fracture, primarily because they have a smaller 
skeleton at peak development and the rapid trabecular bone loss after menopause leads to more 
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disruption of bone integrity (Seeman, 2002). The relatively smaller width of the femoral neck, 
the most common site of hip fracture, is associated with hip fracture in men. This may be 
because of delayed onset of puberty, resulting in reduced growth, reduced periosteal apposition, 
or both (Seeman, 1999). Thus, osteoporosis in elderly men can effectively be viewed as a 
pediatric disease (Roderick, 2003; National Institutes ofHealth, 2001); the consequences of 
prepubescent bone growth set the stage for hip fracture risk in later life. As periosteal expansion 
and cortical thickening is a component of bone growth in males during puberty, delayed puberty 
results in a thinner cortex and reduced BMD when growth halts in young adulthood (Seeman, 
2002). Periosteal apposition determines the width and the load bearing strength of bone, so loss 
of bone strength over time becomes more severe in men than in women because ofthe smaller 
femoral neck diameter. All this aside, men and women with larger peak bone size may tolerate 
bone loss until old age, but overall cortical thinning and increased porosity seen with aging 
contribute to the incidence of hip fracture at a time when muscle weakness, reduced 
coordination, impaired vision, and a propensity to fall increases for all elderly. 
In their 2001 review ofthe literature, Melton, Orwoll, and Wasnich seek evidence that 
BMD can predict fractures comparably in men and women. They compare two seemingly 
contradictory concepts: I) that there is a greater relative risk of fracture per SD change in BMD 
in women than in men, and 2) that the absolute risk of hip fracture in men and women is the 
same (p. 707). To clarify these statements and promote their theory that they do not contradict 
one another, Melton, Orwoll, and Wasnich note that relatively few men have the low BMD 
levels associated with the greatest fracture risk as compared to women, and men are generally 
older than women are when comparable levels are attained. The relative risk differs because men 
are older and less in number- only 4% of men compared to 20% of women rate aT score of -2.5 
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SD- than women when comparable BMD is attained. However, at similar levels ofBMD loss, 
and accounting for bone size differences, the risk of fracture is the same for men and women. 
Based on this information, Melton, Orwoll, and W asnich recommend that clinical decisions on 
diagnosis and treatment rely on absolute fracture risk. More prospective studies are needed to 
evaluate fracture risk in both men and women. Current data is limited that support continued use 
of the WHO diagnostic criteria for osteoporosis and fracture risk in men. The focus of new 
studies must be on the similarities between men and women and less on differences in bone 
formation and patterns of bone loss. 
Discussion 
Implications of osteoporosis in men. Osteoporosis is the most common bone disease in 
men, exceeding all others combined. Fractures due to osteoporosis are a major health problem in 
the U.S., and long-term morbidity and mortality are an increasing public health concern as men 
are more likely than women to become disabled following a fracture (Anderson, 1998). 
Incidence of fracture is treated, but often the underlying condition is not (Bauer, 2000). While 
routine health care for women includes information on average daily requirements for calcium, 
hormone replacement therapy, or screening for osteoporosis, men are probably not receiving 
equivalent information to fight osteoporosis (Ross, 1999). Established health issues in men such 
as prostate disease, blood pressure, and high cholesterol are regularly addressed in routine health 
care but osteoporosis is not. In reality, men are more likely to suffer a hip fracture than have 
prostate cancer (Lyons, 2002). 
BMD findings as an estimate of fracture risk in men. An estimated two million men 
already have osteoporosis, representing 20% of all cases, but the actual number may be higher as 
men are not routinely screened for the disease (Lyons, 2002). BMD testing in men is an 
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important method to diagnose osteoporosis, as overall cortical bone loss is similar to women, 
when adjusted for age (Seeman, 1999). Similarities in men and women, when age-adjusted for 
any given BMD, seem to indicate that the hip BMD cutoff value used in women can be used in 
the diagnosis of osteoporosis in men (Kanis, 2002), but are these cutoff values suitable for men? 
It is possible that DXA findings in men overestimate BMD as men have larger skeletons (Melton 
et a1., 2001), and bone volume is not accounted for. Given that the WHO defines osteoporosis in 
terms ofBMD compared to young, healthy, premenopausal white women, the established 
population mean is not likely to be the same for men. Few studies conclusively determine that 
fracture threshold due to decreased BMD in men is the same or different than in women, and 
there is insufficient data regarding the relationship between BMD and fracture risk in men (Khan 
et a!., 2002) to assure use of accepted measures for women when diagnosing osteoporosis or 
assessing fracture risk in men. 
Screening practices for osteoporosis and fracture risk are not the same for men as for 
women. The NOF recommends that all women over age 65 be considered for bone density 
testing, regardless of the presence of risk factors, but recommendations for men are limited to 
consideration only in the presence of fracture or one of several conditions associated with 
secondary osteoporosis (2002). Although the definition of osteoporosis is based on BMD, is not 
recommended that everyone be tested for BMD. The decision should be based on each 
individual's risk factors, available treatment options, and cost-effectiveness. BMD testing also is 
not indicated unless the results would influence a treatment decision (National Osteoporosis 
Foundation, 1998). Still, it is desirable to identify individuals at risk because risk of hip fracture 
can be greatly reduced with effective treatment (Fogelman, 1999). Men are likely to be in their 
80's, and fewer in number, when reaching the same risk level as women in their 60's (Melton et 
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a!., 2001 ). Cost-effectiveness in the presence of risk factors must be evaluated: will the cost of 
testing outweigh the cost of treatment? This has not been determined for men. 
Research and public health recommendations. Overall, decreased BMD with advancing 
age increases the risk of hip fracture, so minimizing progression of the primary cause, 
osteoporosis, is essential to control the increasing rate of hip fracture in men and women. Major 
factors to be addressed include heightened awareness ofthe disease, and it diagnosis, treatment, 
and prevention. Returning fracture survivors to their previous living situation and prior level of 
function is the goal of rehabilitation; incorporation of the goal to prevent future fractures is 
essential, but often ignored (Kaufman, 2002). To move toward this end, the NOF gives several 
recommendations for knowledge acquisition in many areas of research (1998) and in the public 
sector. Research recommendations are given in Table 8. Public health programs focus on 
awareness and education to reduce osteoporosis and low bone mass. Many campaigns sponsored 
by the NOF are underway, but most target women or girls, such as the "Powerful Bones. 
Powerful Girls" campaign initiated in 1998. Osteoporosis and low bone mass prevention 
programs must specifically target men as well (National Osteoporosis Foundation, 2002). The 
NOF participated in developing goals in the Healthy People 2010 national campaign, but none 
specifically address osteoporosis in men, although some are inclusive. These goals related to 
osteoporosis awareness and prevention are: 1) reduce the proportion of adults with osteoporosis, 
2) reduce the proportion of adults hospitalized with osteoporosis related vertebral fractures, and 
3) reduce hip fractures among older adults (National Osteoporosis Foundation, 2002). Effective 
programs for the prevention of osteoporosis and are essential to minimize the excessive costs 
associated with osteoporotic fractures (National Osteoporosis Foundation, 1998). Striving to 
meet the goals defined by the Healthy People 2010 and "Milk Matters" campaigns will require a 
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long duration, national effort to educate the younger generations in lifestyle adaptations that will 
lead achieving and maintaining optimal peak bone mass to reduce the risk of osteoporotic 
fractures later in life. Older generations, including men and women, and health care providers 
must also be influenced by public health campaigns that focus on diet and lifestyle changes and 
appropriate screening and treatment to reduce the effects of bone loss associated with aging. In 
summary, the NOF states, "a comprehensive national effort aimed at the prevention, diagnosis 
and treatment of osteoporosis and related fractures is necessary to address this debilitating and 
costly disease." 
Table 8 
National Osteoporosis Foundation: Research Recommendations 
Short- and long-term functional and economic 
consequences of fracture 
Randomized controlled trials for effects of standard 
interventions on fracture reduction 
Randomized controlled trials on new treatments for 
fracture reduction 
Studies on long term effects of fracture risk following 
discontinuation of treatment 
Studies between rate of bone loss and fracture 
Studies in all of these areas with regard to men and 
non-white women 
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Note. From "Executive Summary," National Osteoporosis Foundation, 1998, Osteoporosis 
International, (Suppl. 4), p. S6. 
Conclusions 
Osteoporosis in men is expected to rise by 2020 if effective efforts are not successful in 
reducing the prevalence of this disease. It may not be appropriate to use DXA findings to 
diagnose osteoporosis and determine fracture risk in men using criteria established for women as 
with men were not part ofthe baseline population. Having a male baseline population for 
comparison may be significant because of differences in bone growth and development in 
prepuberty and puberty. Thus, controversy exists regarding the use of the same diagnostic tools 
! 
to determine fracture risk in men. More studies are necessary to determine if these measures can I 
be used accurately to diagnose osteoporosis and assess fracture risk in men. I 
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